MerrimanHM. The techniques used to sedate ventilated patients. Inten Care Med1981;7:217–224.
2.
Sedation in the intensive care unit (editorial). Lancet1984;1:1388–1389.
3.
SimpsonPJ, EltringhamRJ. Lorazepam in intensive care. Clin Ther1981;4:150–163.
4.
Miller-JonesCMH, WilliamsJH. Sedation for ventilation: A retrospective study of fifty patients. Anaesthesia1980;35:1104–1107.
5.
GastPH, FisherA, SearJW. Intensive care sedation now. Lancet1984;2:863–864.
6.
KayB.A dose-response relationship for etomidate, with some observations on cumulation. Br J Anaesth1976;48:213–216.
7.
CriadoA, MasedaJ, NavarroE, EscarpaA, VelloF.Induction of anesthesia with etomidate: Hemodynamic study of 36 patients. Br J Anaesth1980;52:803–805.
8.
GoodingJM, WengJT, SmithRA, BernigerGT, KirbyRR. Cardiovascular and pulmonary responses following etomidate induction of anesthesia in patients with demonstrated cardiac disease. Anesth Analg1979;58:40–41.
9.
DoenickeA, LorenzW, BeiglR, . Histamine release after intravenous application of short-acting hypnotics: A comparison of etomidate, althesin (CT134-1) and propanidid. Br J Anaesth1973;45:1097–1104.
10.
EdbrookeDL, NewbyDM, MatherSJ, DixonAM, HebronBS. Safer sedation for ventilated patients: A new application for etomidate. Anaesthesia1982;37:765–771.
11.
BirdTM, EdbrookeDL, NewbyDM, HebronBS. Intravenous sedation for the intubated and spontaneously breathing patient in the intensive care unit. Acta Anaesthesiol Scand1984;28:640–643.
12.
MirandaDR, StoutenbeekCP. Etomidate in the intensive care unit. Lancet1983;2:684–685.
13.
NewbyDM, EdbrookeDL. Influence of sedation on mortality in trauma patients. Lancet1983;1:1381.
14.
DoenickeA.Etomidate (letter). Lancet1983;2:168.
15.
LedinghamIM, WattI.Influence of sedation on mortality in critically ill multiple trauma patients. Lancet1983;1:1270.
16.
FellowsJW, BastowMD, ByrneAJ, AllisonSP. Adrenocortical suppression in multiple injured patients: A complication of etomidate treatment. Br Med J1983;287:1835–1837.
17.
CheeHD, BronsveldW, LipsPTAM, ThisjsLG. Adrenocortical suppression in multiple injured patients: A complication of etomidate treatment. Br Med J1984;288:485.
18.
WattI, LedinghamIM. Mortality amongst multiple trauma patients admitted to an intensive therapy unit. Anaesthesia1984;39:973–981.
19.
WagnerRL, WhitePF, KanPB, RosenthalMH, FeldmanD.Inhibition of adrenal steroidogenesis by the anesthetic etomidate. N Engl J Med1984;310:1415–1421.
20.
AllolioB, StuttmanR, FischerH, LeonhardW, WinkelmannW.Long-term etomidate and adrenocortical suppression. Lancet1983;2:626.
21.
LedinghamIM, FinlayWEI, WattI, McKeeJI. Etomidate and adrenocortical function. Lancet1983;1:1434.
22.
WattI, FraserR, KenyanC, LeverAF, BeastallC, LedinghamJM. Effect of etomidate on adrenocortical function. Br J Surg1984;71:380.
Van LambalgenAA, BronsveldW, Van Der BasGC, ThijsLG, TeuleGJJ. Cardiovascular and biochemical changes in dogs during etomidate-nitrous oxide anaesthesia. Cardiovasc Res1982;16:599–606.
27.
PattonML, GevillNJ, ReynoldsDG, VargishT.Adrenalectomy abolishes and cortisol restores naloxone's beneficial effects on cardiovascular function and survival in canine hemorrhagic shock. Circ Shock1983;10:317–327.
28.
MorganM, LumleyJ, WhitwamJG. Respiratory effects of etomidate. Br J Anaesth1977;49:233–236.
29.
KayB, RollyG.Total intravenous anesthesia with etomidate, III. Some observations in adults. Acta Anaesthesiologica Belgica1977;23:157–164.
30.
HoldcroftA, MorganM, WhitwamJG, LumleyJ.Effect of dose and premedication on induction complica tions with etomidate. Br J Anaesth1976;48:199–205.
31.
SoldMJ. Etomidate: An “immuno logically safe” anaesthetic agent?Anaesthesia1985;40:1014–1015.
32.
LynnAM, OpheimKE, TylerDC. Morphine infusion after pediatric cardiac surgery. Crit Care Med1984;12:863–866.
33.
CuschieriRJ, MorranCG, HowieJC, McArdleCS. Postoperative pain and pulmonary complications: Compar ison of three analgesic regimes. Br J Surg1985;72:495–498.
34.
BriggsGG, BermanML, LangeS, RikerJ, RettenhaierM, DiSaiaP.Morphine: Continuous intravenous infusion versus intramuscular injec tions for postoperative pain relief. Gynecol Oncol1985;22:288–93.
35.
JohnsonMW, MitchWE, WilcoxCS. The cardiovascular actions of morphine and the endogenous opioid peptides. Prog Cardiovasc Dis1985;27:435–450.
36.
BionJF, LoganBK, NewmanPM, . Sedation in intensive care: Morphine and renal function. Inten Care Med1986;12:359–365.
37.
SitarDS, DukePC, OwenJA, BergerL, MitenkoPA. Kinetic disposition of morphine in young males after intravenous loading and maintenance infusions. Can Anaesth Soc J1986;33:1145–1149.
38.
BallM, MooreRA, FisherA, McQuayHJ, AllenMC, SearJ.Renal failure and the use of morphine in intensive care. Lancet1985;1:784–786.
39.
McQuayH, MooreA.Be aware of renal function when prescribing morphine. Lancet1984;2:282–285.
40.
RucquoiM, CamuF.Cardiovascular responses to large doses of alfentanil and fentanyl. Br J Anaesth1983;55:223–230.
41.
YatePM, ThomasD, SebelPS. Alfentanil infusion for sedation and analgesia in intensive care. Lancet1984;2:396–397.
42.
O'ConnorM, EscarpaA, Prys-RobertsC.Ventilatory depression during and after infusion of alfentanil in man. Br J Anaesth1983;55:217–222.
43.
AndrewsCJH, SinclairM, Prys-RobertsC, DyeA.Ventilatory effects during and after continuous infusion of fentanyl or alfentanil. Br J Anaesth1983;55:211–216.
44.
NimmoWS, ToddJG. Fentanyl by constant rate I.V. infusion for postop-erative analgesia. Br J Anaesth1985;57:250–254.
45.
ShaferA, WhitePF, SchuttlerJ, RosenthalMH. Use of a fentanyl infusion in the intensive care unit: Tolerance to its anesthetic effects?Anesthesiology1983;59:245–248.
46.
AndrewsCJH, RobertsonJA, ChapmanJM. Postoperative analgesia with intravenous infusion of alfentanil. Lancet1985;2:671.
47.
HillAB, MahrwoodML, de RosayroAM, KnightPR, JonesRM, BollesRE. Prevention of rigidity during fentanyl-oxygen induction of anesthesia. Anesthesiology1981;55:452–454.
48.
ChristianCMII, WallerJL, Molden hauerCC. Postoperative rigidity following fentanyl anesthesia. Anesthesiology1983;58:275–277.
49.
ChangJ, FishKJ. Acute respiratory arrest and rigidity after anesthesia with sufentanil: A case report. Anesthesiology1985;63:710–711.
50.
GoroszeniukT, MalgosiaA, JonesRM. Generalized grand mal seizure after recovery from uncomplicated fentanyl-etomidate anesthesia. Anesth Analg1986;65:979–981.
51.
RaoTLK, MummaneniN, El-EtrAA. Convulsions: An unusual response to intravenous fentanyl administration. Anesth Analg1982;61:1020–1021.
52.
SafwatAM, DanielD.Grand mal seizure after fentanyl administration. Anesthesiology1983;59:78.
53.
HoienAO. Another case of grand mal seizure after fentanyl administration. Anesthesiology1984;60:388–389.
54.
ScottJC, SarnquistFH. Seizure-like movements during a fentanyl infusion with absence of seizure activity in simultaneous EEG recording. Anesthesiology1985;62:812–814.
55.
SebelPS, LalorJM, FlynnPJ, SimpsonBA. Respiratory depression after alfentanil infusion. Br Med J1984;289:1581–1582.
56.
WaldronHA, CooksonRF. Respiratory depression after alfentanil infusion. Br Med J1985;290:319.
57.
WiggumDC, CorkRC, WeldonST, GandolfiAJ, PerryDS. Postoperative respiratory depression and elevated sufentanil levels in a patient with chronic renal failure. Anesthesiology1985;63:708–710.
58.
BovillJG, SebelPS, BlackburnCL, Oei-LimV, HeykantsJJ. The pharmacokinetics of sufentanil in surgical patients. Anesthesiology1984;61:502–506.
59.
ReillyCS, WoodAJJ, WoodM.Variability of fentanyl pharmacokinetics in man. Anaesthesia1984;40:837–843.
60.
MatherLE. Clinical pharmacokinetics of fentanyl and its newer derivatives. Clin Pharmacokinet1983;8:422–446.
61.
ReitzJA. Alfentanil in anesthesia and analgesia. Drug Intell and Clin Pharm1986;20:335–341.
62.
HullCJ. The pharmacokinetics of alfentanil in man. Br J Anaesth1983;55:157–164.
63.
BentleyJB, BorelJD, NenadRE, GillespieTJ. Age and fentanyl pharmacokinetics. Anesth Analg1982;61:968–971.
64.
BishopMJ. Hemodynamic and gas exchange effects of pancuronium bromide in sedated patients with respiratory failure. Anesthesiology1984;60:369–371.
65.
SomogyiAA, ShanksCA, TriggsEJ. Combined I.V. bolus and infusion of pancuronium bromide. Br J Anaesth1978;50:575–581.
66.
ClyburnPA, MarshallRD. Control of ventilation by continuous infusion of pancuronium bromide. Anaesthesia1981;36:860–862.
67.
SpelmanD.Continuous pancuronium infusion in severe tetanus. Med Aust1980;11:676.
68.
KelmanGR, KennedyBR. Cardiovascular effects of pancuronium in man. Br J Anaesth1971;43:335–338.
69.
FraleyDS, LemoncelliGL, ColemanA.Severe hypertension associated with pancuronium bromide. Anesth Analg1978;57:265–267.
70.
JonesRM, HillAB. Severe hyperten sion associated with pancuronium in a patient with a phaeochromocytoma. Can Anaesth Soc J1981;28:394–396.
71.
LevinN, DillonJB. Cardiovascular effects of pancuronium bromide. Anesth Anal1971;50:808–812.
72.
McIntyreJWR, GainEA. Initial experience during the clinical use of pancuronium bromide. Anesth Anag1971;50:813–818.
73.
BishopMJ. Hemodynamic and gas exchange effects of pancuronium bromide in sedated patients with respiratory failure. Anesthesiology1984;60:369–371.
74.
FroeseAB, BryanAC. Effects of anesthesia and paralysis on diaphrag matic mechanics in man. Anesthesiology1974;41:242–255.
75.
CallananDL. Development of resist ance to pancuronium in adult respiratory distress syndrome. Anesth Analg1985;64:1126–1128.
76.
GronertGA. Resistance to pancuro nium. Anesth Analg1986;65:539.
77.
LaflinMJ. Interaction of pancuro nium and corticosteroids. Anesthesiology1977;47:471–472.
78.
MeyersEF. Partial recovery from pancuronium neuromuscular block ade following hydrocortisone admin istration. Anesthesiology1977;46:148–150.
79.
BelaniKG, AndersonWW, BuckleyJJ. Adverse drug interaction involving pancuronium and aminophylline. Anesth Analg1982;61:473–474.
80.
DollDC, RosenbergH.Antagonism of neuromuscular blockage by theo phylline. Anesth Analg1979;58:139–140.
81.
AzarI, KumanD, BetcherAM. Resistance to pancuronium in an asthmatic patient treated with amin ophylline and steroids. Can Anaesth Soc J1982;29:280–282.
82.
ShanksCA. Pharmacokinetics of the nondepolarizing neuromuscular relaxants applied to calculation of bolus and infusion dosage regimens. Anesthesiology1986;64:72–86.
83.
WardS, NeillEAM. Pharmacokinetics of atracurium in acute hepatic failure (with acute renal failure). Br J Anaesth1983;55:1169–1172.
84.
MillerJonesCMH. Paralysis or sedation for controlled ventilation?Lancet1980;1:312.
85.
GreenD.Paralysis or sedation for controlled ventilation?Lancet1980;1:715.
86.
ChaneyRD. Continuous intravenous drip of pentothal sodium for control of a violent patient during a 41-hour flight. Anesth Analg1968;47:84.
87.
CarlonGC, KahnRC, GoldinerPL, HowlandWS, TurnbullA.Long-term infusion of sodium thiopental hemodynamic and respiratory effects. Crit Care Med1978;6:311–316.
88.
CilipM, ChelluriL, JastremskiM, BailyR.Continuous intravenous infusion of sodium thiopental for managing drug withdrawal syn dromes. Resuscitation1986;13:243–248.
89.
TurcantA, DelhumeauA, Premel-CabcA, . Thiopental pharmacokinetics under conditions of long-term infusion. Anesthesiology1985;63:50–54.
90.
TrisselLA. Handbook on injectable drugs. American Society of Hospital Pharmacists Inc1986.
91.
WeberRJ, OszkoMA, BolenderBJ, BrysiakDL. The intensive care unit syndrome: Causes treatment, and prevention. Drug Intell Clin Pharm1985;19:13–20.
92.
DirksenMSC, VreeTB, DriessenJJ. Midazolam in the intensive care unit (letter). Drug Intell Clin Pharm1986;20:806–806.
93.
LowryKG, DundeeJW, McCleanE, LyonsSM, CarsonIW, OrrIA. Pharmacokinetics of diazepam and midazolam when used for sedation following cardiopulmonary bypass. Br J Anaesth1985;57:883–885.
94.
ShapiroJM, WestphalLM, WhitePF, SladenRN, RosenthalMH. Midazolam for sedation in the intensive care unit: Effect on adrenal function. Anesthesiology1986;64:394–398.
95.
MichalkS, MoncorgeC, FichelleA, FarinottiR, DesmontsJM. Long term midazolam infusion for basal sedation in intensive care: A clinical and pharmacokinetic study. Anesthesiology1986;65:66.
96.
GellerE, HalpernP, KeykinY, RudickV, SorkineP.Midazolam infusion and benzodiazepine antagonist for sedation in ICU: A preliminary report. Anesthesiology1986;65:65.
97.
RevesJG, FragenRJ, VinikHR, GreenblattDJ. Midazolam: Pharmacology and uses. Anesthesiology1985;62:310–324.
98.
American Hospital Formulary Service. Bethesda: American Society of Hospital Pharmacists. 1984:744–746.
99.
DundeeJW, GrayRC. Lorazepam as a sedative amnesic in an intensive care unit. Curr Med Res Opin1976;4:290–295.
100.
NilssonA, TamserP, PerssonP.Midazolam-fentanyl anesthesia for major surgery: Plasma levels of midazolam during prolonged total intravenous anesthesia. Acta Anaesthesiol Scand1986;30:66–69.
101.
GreenblattDJ, ArendtRM, AbernethyDR, GilesHG, SellersEM, ShaderRI. In-vitro quantitation of benzodiazepine lipophilicity: Relation to in-vivo distribution. Br J Anaesth1983;55:985–989.
102.
ArendtRM, GreenblattDJ, DeJongRH, . In-vitro correlates of benzodiazepine cerebrospinal fluid uptake, pharmacodynamic action, and peripheral distribution. J Pharm Exp Ther1983;227:98–106.
103.
PowerSJ, MorganM, ChakrabartiMK. Carbon dioxide response curve following midazolam and diazepam. Br J Anaesth1983;55:837–841.
104.
ForsterA, GardazJP, SuterPM, GemperleM.Respiratory depression by midazolam and diazepam. Anesthesiology1980;53:494–497.
105.
FragenRJ, MeyersSN, BarresiV, CaldwellNJ. Hemodynamic effects of midazolam in cardiac patients. Anesthesiology1979;51:103.
106.
LebowitzPW, CoteME, DanielsAL, . Comparative cardiovascular effects of midazolam and thiopental in healthy patients. Anesth Analg1982;61:771–775.
107.
SmithMT, EadieMJ, BrophyTO. The pharmacokinetics of midazolam in man. Eur J Clin Pharmacol1981;19:271–278.
HiezmannP, EckertM, ZieglerWH. Pharmacokinetics and bioavailability of midazolam in man. Br J Clin Pharmacol1983;16:43–49.
110.
ArendtRM, GreenblattDJ, GarlandWA. Quantitation by gas chromatography of the 1 and 4-hydroxy metabolites of midazolam in human plasma. Pharmacology1984;29:158–164.
111.
RubioF, MiwaBJ, GarlandWA. Determination of midazolam and two metabolites of midazolam in human plasma by gas chromatography-negative chemical-ionization mass spectrometry. J Chromatog1982;233:157–165.
112.
JardineAD, NithianandanS, HallJ.Meptazinol-midazolam combination for postoperative analgesia and sedation. Lancet1983;2:395.
113.
ChengEY, WestphalLM, WhitePF, SladenRN, RosenthalMH. Use of a midazolam infusion for sedation following aortocoronary bypass surgery. Anesthesiology1986;65:67.
114.
MacgilchristAJ, BirnieGG, CookA, . Pharmacokinetics and pharmacodynamics of intravenous midaz olam in patients with severe alcoholic cirrhosis. Gut1986;27:190–195.
115.
VinikHR, RevesJG, GreenblattDJ, AbernethyDR, SmithLR. The pharmacokinetics of midazolam in chronic renal failure patients. Anesthesiology1983;59:390–394.
116.
HarperKW, CollierPS, DundeeJW, ElliottP, HallidayNJ, LowryKG. Age and nature of operation influence the pharmacokinetics of midazolam. Br J Anaesth1985;57:866–871.
117.
BaskinSI, EsdaleA.Is chlordiazep oxide the rational choice among benzodiazepines?Pharmacotherapy1982;2:110–119.
118.
McDonaldCF, ThomasonSA, ScottNC, ScottW, GrantIWB, CromptonGK. Benzodiazepine opiate antagonism: A problem in intensive-care therapy. Intensive Care Med1986;12:39–42.
119.
CohenR, FinnH, SteenSN. Effects of diazepam and meperidine, alone and in combination on respiratory responses to carbon dioxide. Anesth Analg1969;48:353.
120.
SteenSN, WeitznerSW, AmahaK, MartinezR.The effect of chlordia zepoxide and pethidine, alone and in combination, on the respiratory responses to CO2. Br J Anaesth1967;39:459.
121.
SadoveMS, BalagotRC, McGrathJM. Effects of chlordiazepoxide and diazepam on the influence of meper idine on the respiratory responses to carbon dioxide. J New Drugs1965;5:121.
122.
WeisJ.Morphine antagonistic effect of chlordiazepoxide. Experientia1969;25:381.
123.
MantegazzaP, ParentiM, TammisoR, VitP, ZambottiF, ZontaN.Modification of the antinociceptive effect of morphine by centrally administered diazepam and midaz olam. Br J Pharmacol1982;75:369.
